ESOPHAGEAL CANCER
Clinical trials for ESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug INCB062079 tested in 25 patients, study halted early
Disease control TerminatedThis early-phase study tested the safety of a new drug, INCB062079, in 25 people with advanced liver cancer or other solid tumors. The goal was to find a safe dose and see how well patients tolerated the treatment. The study was terminated early, so results are limited.
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 03:19 UTC
-
Experimental cancer drug trial halted after early testing
Disease control TerminatedThis study tested a new drug called TAK-500, alone or with pembrolizumab, in 61 adults with advanced solid tumors like pancreatic, liver, and lung cancer. The goal was to check safety and see if the drug could shrink tumors. The trial was terminated early, so results are limited.
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 03:06 UTC
-
Experimental combo for rare Gene-Mutated cancers halted early
Disease control TerminatedThis study tested a new drug (PRT3789) combined with the immunotherapy pembrolizumab in people with advanced cancers that have a specific genetic change called SMARCA4. The goal was to see if the combination was safe and could shrink tumors. The study was terminated early after e…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Targeted drug shows promise for rare genetic cancers
Disease control TerminatedThis study tested the drug niraparib in 22 adults with advanced solid tumors (like breast, lung, or pancreatic cancer) that have a specific genetic change called a PALB2 mutation. The goal was to see if niraparib could shrink tumors or slow their growth. The study was stopped ear…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
Feeding delay after esophageal surgery may protect muscle mass
Knowledge-focused TerminatedThis study looked at whether delaying feeding for a few days after esophageal cancer surgery could help preserve muscle and speed up recovery. It involved 239 adults with esophageal cancer who were scheduled for surgery. The goal was to compare the usual early feeding approach wi…
Matched conditions: ESOPHAGEAL CANCER
Phase: NA • Sponsor: University Hospital, Gasthuisberg • Aim: Knowledge-focused
Last updated May 26, 2026 03:10 UTC
-
Robotic surgery for esophageal cancer tested in canadian trial
Knowledge-focused TerminatedThis study aimed to see if it's possible to run a larger trial comparing robotic-assisted minimally invasive surgery (RAMIE) to the standard open surgery for esophageal cancer. It involved 24 adults with stage I-III esophageal cancer. The main goal was to measure how many patient…
Matched conditions: ESOPHAGEAL CANCER
Phase: NA • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC